Surgical management of de novo metastatic meningioma of the spine: An underestimated issue for WHO grade II/III meningiomas

Meningioma is a slow-growing neoplasm derived from meningothelial cells. Extradural metastasis of WHO grade II/III meningiomas is relatively rare, and spinal metastatic meningiomas (SMM) have only been described in individual case reports. The aim of the present study is to discuss the clinical feat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical neurology and neurosurgery 2021-11, Vol.210, p.106995-106995, Article 106995
Hauptverfasser: Jia, Qi, Wu, Zhipeng, Chu, Ruitong, Zhao, Chenglong, Wang, Ting, Zhou, Zhenhua, Cai, Xiaopan, Yang, Xinghai, Xiao, Jianru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106995
container_issue
container_start_page 106995
container_title Clinical neurology and neurosurgery
container_volume 210
creator Jia, Qi
Wu, Zhipeng
Chu, Ruitong
Zhao, Chenglong
Wang, Ting
Zhou, Zhenhua
Cai, Xiaopan
Yang, Xinghai
Xiao, Jianru
description Meningioma is a slow-growing neoplasm derived from meningothelial cells. Extradural metastasis of WHO grade II/III meningiomas is relatively rare, and spinal metastatic meningiomas (SMM) have only been described in individual case reports. The aim of the present study is to discuss the clinical features and treatments of SMM patients. Fourteen SMM patients who received surgery in our center between 2010 and 2020 were reviewed retrospectively. Possible prognostic factors affecting local progression-free survival (LPFS) and overall survival (OS) were analyzed by log-rank analysis. Our series comprised nine men and five women, with a median age of 49 years. The interval from the primary treatment to SMM varied from 1 to 11 years. Lesions were mainly located in the lumbar-sacral region (7/14, 50.0%), followed by the thoracic spine (5/14, 35.7%) and cervical (2/14, 14.3%) spine. The median follow-up period was 42.7 months, during which six patients (42.9%) passed away. Local tumor progression was detected in four patients (28.6%). Log-rank analysis indicated that circumferential surgery was associated with good LPFS, whereas WHO grade III and visceral metastasis were factors adversely affecting OS. SMM is a challenging clinical entity, usually occurring in the fourth to fifth decades of life. Circumferential surgery is associated with good LPFS. WHO grade III and visceral metastasis are factors adversely affecting OS of patients with SMM. Long-term follow-up is recommended for patients who have received surgical treatment for primary meningiomas (Simpson Grade III/IV), especially for WHO III lesions. •Spinal metastatic meningioma (SMM) is a challenging clinical entity, usually occurring in the fourth to fifth decades.•Circumferential surgery is associated with good LPFS, and radiotherapy is a useful supplementary treatment after debulking surgery.•WHO grade III and visceral metastasis are adverse factors for overall survival (OS) of SMM patients.
doi_str_mv 10.1016/j.clineuro.2021.106995
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2590135995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303846721005242</els_id><sourcerecordid>2590135995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-3a9057a0a966c9fc347ff6204f4121917f401e8c43c7076727cf6d50de5d5acf3</originalsourceid><addsrcrecordid>eNqFkcFrHCEUxiW0NNu0_0IQcullNjrO6JhTQ2ibgUAObchRrD43LjO6VScQ8s_XZZNSeum7-JDf-_x8H0KnlKwpofx8uzaTD7CkuG5JS-sll7I_Qis6iLbhkg9v0Iowwpqh4-IYvc95SwhhjA_v0DHrBO1rrdDz9yVtvNETnnXQG5ghFBwdtoBDfIx4hqJz0cWb2gYfNj7Oeg-UB8B5Vy1c4MuAl2AhQS5-1gUs9jkvgF1M-P76Fm-SrnLjeD6O418q-QN66_SU4ePLeYLuvn75cXXd3Nx-G68ubxrDJC8N05L0QhMtOTfSmWreOd6SznW0pZIK1xEKg-mYEURw0QrjuO2Jhd722jh2gj4ddHcp_lqqSzX7bGCadIC4ZNX2klDW1_1V9OwfdBuXFKq7PSUJ55TxSvEDZVLMOYFTu1R_np4UJWofj9qq13jUPh51iKcOnr7ILz9nsH_GXvOowOcDAHUfjx6SysZDMGB9AlOUjf5_b_wGFiOkFw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2599066136</pqid></control><display><type>article</type><title>Surgical management of de novo metastatic meningioma of the spine: An underestimated issue for WHO grade II/III meningiomas</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Jia, Qi ; Wu, Zhipeng ; Chu, Ruitong ; Zhao, Chenglong ; Wang, Ting ; Zhou, Zhenhua ; Cai, Xiaopan ; Yang, Xinghai ; Xiao, Jianru</creator><creatorcontrib>Jia, Qi ; Wu, Zhipeng ; Chu, Ruitong ; Zhao, Chenglong ; Wang, Ting ; Zhou, Zhenhua ; Cai, Xiaopan ; Yang, Xinghai ; Xiao, Jianru</creatorcontrib><description>Meningioma is a slow-growing neoplasm derived from meningothelial cells. Extradural metastasis of WHO grade II/III meningiomas is relatively rare, and spinal metastatic meningiomas (SMM) have only been described in individual case reports. The aim of the present study is to discuss the clinical features and treatments of SMM patients. Fourteen SMM patients who received surgery in our center between 2010 and 2020 were reviewed retrospectively. Possible prognostic factors affecting local progression-free survival (LPFS) and overall survival (OS) were analyzed by log-rank analysis. Our series comprised nine men and five women, with a median age of 49 years. The interval from the primary treatment to SMM varied from 1 to 11 years. Lesions were mainly located in the lumbar-sacral region (7/14, 50.0%), followed by the thoracic spine (5/14, 35.7%) and cervical (2/14, 14.3%) spine. The median follow-up period was 42.7 months, during which six patients (42.9%) passed away. Local tumor progression was detected in four patients (28.6%). Log-rank analysis indicated that circumferential surgery was associated with good LPFS, whereas WHO grade III and visceral metastasis were factors adversely affecting OS. SMM is a challenging clinical entity, usually occurring in the fourth to fifth decades of life. Circumferential surgery is associated with good LPFS. WHO grade III and visceral metastasis are factors adversely affecting OS of patients with SMM. Long-term follow-up is recommended for patients who have received surgical treatment for primary meningiomas (Simpson Grade III/IV), especially for WHO III lesions. •Spinal metastatic meningioma (SMM) is a challenging clinical entity, usually occurring in the fourth to fifth decades.•Circumferential surgery is associated with good LPFS, and radiotherapy is a useful supplementary treatment after debulking surgery.•WHO grade III and visceral metastasis are adverse factors for overall survival (OS) of SMM patients.</description><identifier>ISSN: 0303-8467</identifier><identifier>EISSN: 1872-6968</identifier><identifier>DOI: 10.1016/j.clineuro.2021.106995</identifier><identifier>PMID: 34715555</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Aged ; Brain cancer ; Case reports ; Child ; Circumferential resection ; Disease Management ; Female ; Follow-Up Studies ; Humans ; Male ; Medical imaging ; Medical prognosis ; Meningeal Neoplasms - diagnostic imaging ; Meningeal Neoplasms - surgery ; Meningioma ; Meningioma - diagnostic imaging ; Meningioma - surgery ; Metastases ; Metastasis ; Middle Aged ; Neoplasm Grading ; Neurology ; Patients ; Radiotherapy ; Sacrum ; Spinal Neoplasms - diagnostic imaging ; Spinal Neoplasms - surgery ; Spine (lumbar) ; Spine (thoracic) ; Spine metastasis ; Surgery ; Survival analysis ; Tumors ; WHO grade ; Young Adult</subject><ispartof>Clinical neurology and neurosurgery, 2021-11, Vol.210, p.106995-106995, Article 106995</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><rights>2021. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-3a9057a0a966c9fc347ff6204f4121917f401e8c43c7076727cf6d50de5d5acf3</citedby><cites>FETCH-LOGICAL-c396t-3a9057a0a966c9fc347ff6204f4121917f401e8c43c7076727cf6d50de5d5acf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2599066136?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982,64370,64372,64374,72224</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34715555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jia, Qi</creatorcontrib><creatorcontrib>Wu, Zhipeng</creatorcontrib><creatorcontrib>Chu, Ruitong</creatorcontrib><creatorcontrib>Zhao, Chenglong</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Zhou, Zhenhua</creatorcontrib><creatorcontrib>Cai, Xiaopan</creatorcontrib><creatorcontrib>Yang, Xinghai</creatorcontrib><creatorcontrib>Xiao, Jianru</creatorcontrib><title>Surgical management of de novo metastatic meningioma of the spine: An underestimated issue for WHO grade II/III meningiomas</title><title>Clinical neurology and neurosurgery</title><addtitle>Clin Neurol Neurosurg</addtitle><description>Meningioma is a slow-growing neoplasm derived from meningothelial cells. Extradural metastasis of WHO grade II/III meningiomas is relatively rare, and spinal metastatic meningiomas (SMM) have only been described in individual case reports. The aim of the present study is to discuss the clinical features and treatments of SMM patients. Fourteen SMM patients who received surgery in our center between 2010 and 2020 were reviewed retrospectively. Possible prognostic factors affecting local progression-free survival (LPFS) and overall survival (OS) were analyzed by log-rank analysis. Our series comprised nine men and five women, with a median age of 49 years. The interval from the primary treatment to SMM varied from 1 to 11 years. Lesions were mainly located in the lumbar-sacral region (7/14, 50.0%), followed by the thoracic spine (5/14, 35.7%) and cervical (2/14, 14.3%) spine. The median follow-up period was 42.7 months, during which six patients (42.9%) passed away. Local tumor progression was detected in four patients (28.6%). Log-rank analysis indicated that circumferential surgery was associated with good LPFS, whereas WHO grade III and visceral metastasis were factors adversely affecting OS. SMM is a challenging clinical entity, usually occurring in the fourth to fifth decades of life. Circumferential surgery is associated with good LPFS. WHO grade III and visceral metastasis are factors adversely affecting OS of patients with SMM. Long-term follow-up is recommended for patients who have received surgical treatment for primary meningiomas (Simpson Grade III/IV), especially for WHO III lesions. •Spinal metastatic meningioma (SMM) is a challenging clinical entity, usually occurring in the fourth to fifth decades.•Circumferential surgery is associated with good LPFS, and radiotherapy is a useful supplementary treatment after debulking surgery.•WHO grade III and visceral metastasis are adverse factors for overall survival (OS) of SMM patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Brain cancer</subject><subject>Case reports</subject><subject>Child</subject><subject>Circumferential resection</subject><subject>Disease Management</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medical prognosis</subject><subject>Meningeal Neoplasms - diagnostic imaging</subject><subject>Meningeal Neoplasms - surgery</subject><subject>Meningioma</subject><subject>Meningioma - diagnostic imaging</subject><subject>Meningioma - surgery</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neurology</subject><subject>Patients</subject><subject>Radiotherapy</subject><subject>Sacrum</subject><subject>Spinal Neoplasms - diagnostic imaging</subject><subject>Spinal Neoplasms - surgery</subject><subject>Spine (lumbar)</subject><subject>Spine (thoracic)</subject><subject>Spine metastasis</subject><subject>Surgery</subject><subject>Survival analysis</subject><subject>Tumors</subject><subject>WHO grade</subject><subject>Young Adult</subject><issn>0303-8467</issn><issn>1872-6968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkcFrHCEUxiW0NNu0_0IQcullNjrO6JhTQ2ibgUAObchRrD43LjO6VScQ8s_XZZNSeum7-JDf-_x8H0KnlKwpofx8uzaTD7CkuG5JS-sll7I_Qis6iLbhkg9v0Iowwpqh4-IYvc95SwhhjA_v0DHrBO1rrdDz9yVtvNETnnXQG5ghFBwdtoBDfIx4hqJz0cWb2gYfNj7Oeg-UB8B5Vy1c4MuAl2AhQS5-1gUs9jkvgF1M-P76Fm-SrnLjeD6O418q-QN66_SU4ePLeYLuvn75cXXd3Nx-G68ubxrDJC8N05L0QhMtOTfSmWreOd6SznW0pZIK1xEKg-mYEURw0QrjuO2Jhd722jh2gj4ddHcp_lqqSzX7bGCadIC4ZNX2klDW1_1V9OwfdBuXFKq7PSUJ55TxSvEDZVLMOYFTu1R_np4UJWofj9qq13jUPh51iKcOnr7ILz9nsH_GXvOowOcDAHUfjx6SysZDMGB9AlOUjf5_b_wGFiOkFw</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Jia, Qi</creator><creator>Wu, Zhipeng</creator><creator>Chu, Ruitong</creator><creator>Zhao, Chenglong</creator><creator>Wang, Ting</creator><creator>Zhou, Zhenhua</creator><creator>Cai, Xiaopan</creator><creator>Yang, Xinghai</creator><creator>Xiao, Jianru</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>Surgical management of de novo metastatic meningioma of the spine: An underestimated issue for WHO grade II/III meningiomas</title><author>Jia, Qi ; Wu, Zhipeng ; Chu, Ruitong ; Zhao, Chenglong ; Wang, Ting ; Zhou, Zhenhua ; Cai, Xiaopan ; Yang, Xinghai ; Xiao, Jianru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-3a9057a0a966c9fc347ff6204f4121917f401e8c43c7076727cf6d50de5d5acf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Brain cancer</topic><topic>Case reports</topic><topic>Child</topic><topic>Circumferential resection</topic><topic>Disease Management</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medical prognosis</topic><topic>Meningeal Neoplasms - diagnostic imaging</topic><topic>Meningeal Neoplasms - surgery</topic><topic>Meningioma</topic><topic>Meningioma - diagnostic imaging</topic><topic>Meningioma - surgery</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neurology</topic><topic>Patients</topic><topic>Radiotherapy</topic><topic>Sacrum</topic><topic>Spinal Neoplasms - diagnostic imaging</topic><topic>Spinal Neoplasms - surgery</topic><topic>Spine (lumbar)</topic><topic>Spine (thoracic)</topic><topic>Spine metastasis</topic><topic>Surgery</topic><topic>Survival analysis</topic><topic>Tumors</topic><topic>WHO grade</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jia, Qi</creatorcontrib><creatorcontrib>Wu, Zhipeng</creatorcontrib><creatorcontrib>Chu, Ruitong</creatorcontrib><creatorcontrib>Zhao, Chenglong</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Zhou, Zhenhua</creatorcontrib><creatorcontrib>Cai, Xiaopan</creatorcontrib><creatorcontrib>Yang, Xinghai</creatorcontrib><creatorcontrib>Xiao, Jianru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neurology and neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jia, Qi</au><au>Wu, Zhipeng</au><au>Chu, Ruitong</au><au>Zhao, Chenglong</au><au>Wang, Ting</au><au>Zhou, Zhenhua</au><au>Cai, Xiaopan</au><au>Yang, Xinghai</au><au>Xiao, Jianru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical management of de novo metastatic meningioma of the spine: An underestimated issue for WHO grade II/III meningiomas</atitle><jtitle>Clinical neurology and neurosurgery</jtitle><addtitle>Clin Neurol Neurosurg</addtitle><date>2021-11</date><risdate>2021</risdate><volume>210</volume><spage>106995</spage><epage>106995</epage><pages>106995-106995</pages><artnum>106995</artnum><issn>0303-8467</issn><eissn>1872-6968</eissn><abstract>Meningioma is a slow-growing neoplasm derived from meningothelial cells. Extradural metastasis of WHO grade II/III meningiomas is relatively rare, and spinal metastatic meningiomas (SMM) have only been described in individual case reports. The aim of the present study is to discuss the clinical features and treatments of SMM patients. Fourteen SMM patients who received surgery in our center between 2010 and 2020 were reviewed retrospectively. Possible prognostic factors affecting local progression-free survival (LPFS) and overall survival (OS) were analyzed by log-rank analysis. Our series comprised nine men and five women, with a median age of 49 years. The interval from the primary treatment to SMM varied from 1 to 11 years. Lesions were mainly located in the lumbar-sacral region (7/14, 50.0%), followed by the thoracic spine (5/14, 35.7%) and cervical (2/14, 14.3%) spine. The median follow-up period was 42.7 months, during which six patients (42.9%) passed away. Local tumor progression was detected in four patients (28.6%). Log-rank analysis indicated that circumferential surgery was associated with good LPFS, whereas WHO grade III and visceral metastasis were factors adversely affecting OS. SMM is a challenging clinical entity, usually occurring in the fourth to fifth decades of life. Circumferential surgery is associated with good LPFS. WHO grade III and visceral metastasis are factors adversely affecting OS of patients with SMM. Long-term follow-up is recommended for patients who have received surgical treatment for primary meningiomas (Simpson Grade III/IV), especially for WHO III lesions. •Spinal metastatic meningioma (SMM) is a challenging clinical entity, usually occurring in the fourth to fifth decades.•Circumferential surgery is associated with good LPFS, and radiotherapy is a useful supplementary treatment after debulking surgery.•WHO grade III and visceral metastasis are adverse factors for overall survival (OS) of SMM patients.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34715555</pmid><doi>10.1016/j.clineuro.2021.106995</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0303-8467
ispartof Clinical neurology and neurosurgery, 2021-11, Vol.210, p.106995-106995, Article 106995
issn 0303-8467
1872-6968
language eng
recordid cdi_proquest_miscellaneous_2590135995
source MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Adolescent
Adult
Aged
Brain cancer
Case reports
Child
Circumferential resection
Disease Management
Female
Follow-Up Studies
Humans
Male
Medical imaging
Medical prognosis
Meningeal Neoplasms - diagnostic imaging
Meningeal Neoplasms - surgery
Meningioma
Meningioma - diagnostic imaging
Meningioma - surgery
Metastases
Metastasis
Middle Aged
Neoplasm Grading
Neurology
Patients
Radiotherapy
Sacrum
Spinal Neoplasms - diagnostic imaging
Spinal Neoplasms - surgery
Spine (lumbar)
Spine (thoracic)
Spine metastasis
Surgery
Survival analysis
Tumors
WHO grade
Young Adult
title Surgical management of de novo metastatic meningioma of the spine: An underestimated issue for WHO grade II/III meningiomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T17%3A32%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20management%20of%20de%20novo%20metastatic%20meningioma%20of%20the%20spine:%20An%20underestimated%20issue%20for%20WHO%20grade%20II/III%20meningiomas&rft.jtitle=Clinical%20neurology%20and%20neurosurgery&rft.au=Jia,%20Qi&rft.date=2021-11&rft.volume=210&rft.spage=106995&rft.epage=106995&rft.pages=106995-106995&rft.artnum=106995&rft.issn=0303-8467&rft.eissn=1872-6968&rft_id=info:doi/10.1016/j.clineuro.2021.106995&rft_dat=%3Cproquest_cross%3E2590135995%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2599066136&rft_id=info:pmid/34715555&rft_els_id=S0303846721005242&rfr_iscdi=true